Human saliva contains high and low molecular weight mucin glycoproteins, that are distinct Recently the gene encoding low molecular weight salivary mucin was cloned and designated MUC7, whereas the primary structure of high molecular weight salivary mucin is unclear. Furthermore, the expression patterns of high and low molecular weight salivary mucins in salivary glands have been debated. We have previously generated monoclonal antibodies specific for the peptide cores of salivary mucins. In the present study a monoclonal antibody specific for high molecular weight salivary mucin was used to screen a human salivary gland cDNA library. A single clone, SAL1, was identified and found to be encoded by tracheobronchial mucin gene MUC5B. A previously reported partial cDNA sequence from salivary mucin was linked to SAL.1JMVC5B by genomic cloning and reverse transcriptase-polymerase chain reaction. Northern analysis of salivary gland RNA probed with SAL1 suggested that MUC5B was highly expressed in salivary glands. In situ hybridization was performed with a SAL1/MUC5B probe and a MUC7 probe. All mucous cells from the submandibular, sublingual, palatine, and labial glands labeled with the MUC5B probe, while serous cells labeled with the MUC7 probe. These findings were in accordance with our previous immunohistological results of the cellular localizations of salivary mucins. The results suggest that MUC5B is identical to or a major fraction of high molecular weight salivary mucin, and that MUC5B is expressed in all mucous cells of salivary glands. In contrast MUC7 is expressed in serous cells of salivary glands except the parotid glands.
Recently, Troxler et al. have cloned a partial cDNA sequence (pSM2-l) from sublingual gland. The pSM2-l sequence is not identical to any known mucins and was proposed to represent a novel mucin. pSM2-l does not contain tandem repeats, but exhibits amino acid sequence similarity to the C-termini of MUC5AC, MUC2 and von Willebrand factor (Troxler et al., 1995) . Northern blot analysis of RNA from different salivary glands probed with pSM2-1 revealed an intense hybridization signal from sublingual glands but only a weak signal from submandibular glands (Troxler et al., 1995) .
Previous imrnunohistochemical studies of MG1 and MG2 expression in salivary glands have suggested that MG1 is produced in a subpopulation of mucous cells within some salivary glands (Cohen et al., 1990) , whereas MG2 has been reported to be produced in a different subpopulation of mucous cells (Cohen et al., 1991) . Northern analysis of RNA from different salivary glands suggests that MUC7 (MG2) is expressed in sublingual and submandibular glands. The parotid glands, which do not contain mucous cells, do not express MUC7 (Bobek et al., 1993) .
We have previously produced and characterized monoclonal antibodies (MAbs) to the peptide cores of MG1 and MG2 (Nielsen et al., 1996) . Immunohistology using these MAbs revealed expression patterns of MG1 and MG2 that were different from those previously reported. We found MG1 expression in all mucous cells of salivary glands while MG2 expression was localized to some serous cells. In the present study the anti-MGl MAb was used to isolate a cDNA clone from a salivary gland cDNA library. Sequence analysis of this cDNA revealed that it was encoded by the MUC5B gene. Furthermore, Southern analysis and reverse transcriptase-polymerase chain reaction (RT-PCR) established that pSM2-l represented the 3' end of the MUC5B gene. Northern analyses suggested that MUC5B was highly expressed in salivary glands, and in situ hybridization confirmed that MUC5B was expressed in all mucous cells of all salivary glands, suggesting that MUC5B represented a major fraction of MG1. In contrast, MUC7 expression was localized to serous cells by in situ hybridization.
The nucleotide sequence reported in this article has been submitted to the GenBank/EMBL Data Bank with accession number U63836.
Introduction
Two distinct human salivary mucins, high molecular weight salivary mucin (MG1) and low molecular weight salivary mucin (MG2), are found in submandibular-sublingual saliva (Ramasubbu et al., 1991) . MG2 is a M r 150,000-250,000 monomer that is encoded by the MUC7 gene (Bobek et al., 1993) . The primary structure of the MG1 apomucin(s) is unclear. Previously, Audie et al. have detected MUC5B expression in sublingual gland by in situ hybridization (Audie et al., 1993) .
Results

Screening of a salivary gland cDNA library with MAb PANH2
Screening of 150,000 clones of a cDNA expression library from sublingual and submandibular salivary glands with MAb PANH2 yielded a single positive clone SAL1, which contained an 849 bp insert encoding an open reading frame of 283 amino acids (Figure 1 ). The 5' end of SAL1 encoded a sequence predicted to be cysteine-rich, while the 3' end of SAL1 (from nucleotide 379 to 849) contained 5.4 repeats of 87 base pairs (bp). A BLAST algorithm DNA homology search against the GenBank database revealed that the 3' end of SALl was nearly identical to MUC5B cDNA clones JER 57, JUL 10, JER 28, and JUL 7 (Dufosse et al, 1993) . Of these, JUL 7 showed the highest degree of similarity to the tandem repeat region of SALl (Figure 1 ). This region of SALl was not 100% identical to any published MUC5B clones, which is not surprising since the MUC5B tandem repeat is characterized by degeneracy and numerous insertions and deletions (Dufosse et al., 1993) , and since SALl and the previously published MUC5B cDNA clones may well encode different parts of the MUC5B tandem repeat The SALl sequence from nucleotide 165 to 399 was highly similar to the 5' end of JER 57 (Figure 1 ), a region that has been reported to have amino acid sequence similarity to cysteine-rich domains in MUC5AC and MUC2 (Guyonnet Duperat et al, 1995) . In agreement with this, the translated 5' end of SALl (nucleotides 1-342) was also found to have amino acid sequence similarity to cysteine-rich regions found in MUC5AC (JER47, JUL32) (Guyonnet Duperat et al., 1995) , human gastric mucin (Klomp et al., 1995) , tracheobronchial mucin (Meerzaman et al., 1994) , MUC2 (Gum et al, 1992) , and Mus muscularis gastric mucin (Shekels et al., 1995) (Figure 2) . The functional roles of these domains are unclear.
pSM2-l represented the 3' end of MUC5B
The cDNA clone pSM2-l was previously isolated from a human sublingual gland cDNA library and proposed to encode a novel MG1 mucin based on sequence similarity to the Ctermini of other known mucins and von Willebrand Factor (Troxler et al, 1995) . In order to analyze the relationship between SALl and pSM2-1, a PI genomic clone containing pSM2-l was isolated, and Southern analysis showed that it contained SALl as well. The PI clone was identified with primers from pSM2-l, which by genomic PCR yielded a product which was hybridization positive with a nested pSM2-l primer. DNA was purified from one clone, DMPC-HFF#1-1104-H12, digested with EcoRI, and Southern blotted ( Figure  3A ). Both SALl and pSM2-l hybridized to a 25 kbp restriction fragment or co-migrating fragments of DMPC-HFF# 1-1104-H12 (Figure 3 ), suggesting that both SALl and pSM2-l were encoded by the same gene. Furthermore, RT-PCR with an antisense primer from pSM2-l and a sense primer from the 3' end of JER 57 with salivary gland RNA yielded a 2.3 kbp band which was hybridization positive with a nested primer from pSM2-l. By direct sequencing of this RT-PCR product it was found to contain the expected 3' sequence from pSM2-l and 5' sequence from MUC5B tandem repeats (not shown). Amino acid sequence alignments of the deduced N-tenninal of SAL1 and cysteine-rich regions from other mucins. Aligned residues identical to SAL1 are indicated by boxes. JER47 and JER32 are from the tandem repeat region of MUC5AC (Guyonnet Duperal et al, 1995) . HGM-1, human gastric mucin (Klomp el aL, 1995) ; TBM, tracheobronchial mucin (Meerzaman et al, 1994) , MUC2 (Gum et al, 1992) ; MUS M., Mas muscularis gastric mucin (Shekels etaL, 1995) .
Expression of MUC5B in salivary glands
Northern blot analysis of salivary gland poly(A) + RNA with SAL1 showed an intense, polydisperse hybridization signal. This type of signal was similar to that observed for MUC5B in tracheobronchial tissue (Dufosse et al., 1993) and for other mucin transcripts. No hybridization signal was detected with irrelevant poly(A) + RNA (Figure 4 ).
In situ hybridization of MUC5B and MUC7 in salivary glands
An oligonucleotide probe antisense to the 3'end of SAL1 (the MUC5B tandem repeat) hybridized to all mucous cells in the submandibular, sublingual, palatine, and labial salivary glands. A probe directed to the tandem repeat of MUC7 hybridized to serous cells and demilunes and possibly some myoepithelial and duct cells in the submandibular, sublingual, and labial salivary glands ( Figure 5 ).
Discussion
We have previously reported the generation and characterization of MAbs directed to the peptide cores of salivary mucins MG1 and MG2 (MUC7). Immunohistological studies using these MAbs showed that MG1 and MG2 are differentially expressed in salivary glands. MG1, defined by MAb PANH2, is expressed in all mucous cells of all salivary glands, whereas MG2, defined by MAb PANH3, is expressed in a subpopulation of serous cells in all salivary glands except the parotid gland (Nielsen et al., 1996) . In the present study we have isolated a cDNA clone representing MG1 using the anti-MGl MAb PANH2. This cDNA, SAL1, was identified as the product of tracheobronchial mucin gene MUC5B. MUC5B has previously been partially sequenced and is characterized by four partially homologous cDNA clones that encode 87 bp tandem repeats (Dufosse et al., 1993) , but 5' and 3' sequences of MUC5B have not been reported. MUC5B expression has previously been detected in mucous cells from submucosal glands in bronchus, endocervix, and glandular acini of the sublingual gland by in situ hybridization (Audie et al., 1993) . This is in agreement with our finding of a MG1 encoded by the MUC5B gene. It thus interesting to note that the same apomucin is expressed in salivary glands as well as in airways.
Troxler et al. recently isolated a cDNA clone from sublingual gland, pSM2-l, using an antiserum to MG1. Northern blot analyses showed that pSM2-l transcripts were mainly expressed in sublingual glands and only weakly expressed in submandibular glands (Troxler et al, 1995) . The immunohistological staining pattern of the anti-MGl serum used by Troxler et al. has not been reported, but our previous immunohistological studies of MG1 expression with MAb PANH2 indicated that MG1 was expressed in all mucous cells in salivary glands. In order to clarify this issue, the relationship between SAL1/MUC5B and pSM2-l was examined. By genomic cloning and RT-PCR we established that pSM2-l represented the 3' end of the MUC5B gene. The weak hybridization signal observed with pSM2-l in Northern blot analysis of submandibular gland RNA by Troxler et al. may be due to the low ratio of mucous to serous acini within the submandibular glands, which may make the detection of mucin transcripts by Northern blot analysis difficult Alternatively, pSM2-l may represent a MUC5B splice variant that is not expressed in the submandibular glands. This seems unlikely, however, since pSM2-l shows amino acid sequence similarity to a domain which has been implicated in the dimerization of von Willebrand Factor (Voorberg et al., 1991) , and since recent studies suggest that dimerization of both human MUC2 and porcine submaxillary mucin monomers precedes polymerization analo- gous to von Willebrand Factor polymerization (Asker et al, 1995; Perez-Vilar et al., 1996) . The identification of pSM2-l as the 3' end of the MUC5B transcript further suggested that MG1 predominantly was encoded by the MUC5B gene. Furthermore, Northern analyses showed that MUC5B was highly expressed in salivary glands (Figure 4) . Cohen et al. have previously localized MG1 to a subpopulation of mucous cells by immunohistology with MAb 3/E8. This MAb, however, was found to recognize a carbohydratecontaining epitope of MG1 (Cohen et al, 1990) , and therefore may not accurately reflect the tissue distribution of the MG1 apomucin. Previous reports indicate that mucous cells from the same individual show heterogenous reactivity with anticarbohydrate antibodies (Cossu et al, 1990) . Thus, MAb 3/E8 may recognize a glycoform of MG1 that is synthesized only in a subpopulation of mucous cells.
In order to confirm the immunohistological staining pattern of MAb PANH2 (Nielsen et al, 1996) , in situ hybridization was performed with a MUC5B probe. This confirmed that MUC5B was expressed in all mucous cells of the sublingual, submandibular, palatine, and labial salivary glands.
The labeling of submandibular, sublingual and labial serous cells with varying staining intensity by an in situ hybridization probe against MUC7 also confirmed our previous finding with anti-MG2 MAb PANH3 (Nielsen et al., 1996) . Since the signal detected by in situ hybridization was stronger than the signal detected with MAb PANH3, we cannot exclude the possibility that all serous cells in the submandibular and sublingual glands expressed MUC7 in addition to some intercalated ducts and possibly myoepithelial cells. These results are in contrast to a previous report of the tissue distribution of MG2 which localized MG2 to a subpopulation of mucous cells by immunohistology (Cohen et al, 1991) . Thus, our results indicate that mucous cells are specialized for secretion of mucin in the form of large polymers (MG1) as has been described for other secretory mucins from mucin producing cells of the respiratory and digestive tracts (Audie et al., 1993) , whereas MG2 which is secreted as a M T 150,000-250,000 monomer is synthesized in some serous cells. These results harmonize with previous findings indicating that different carbohydrate side chains are attached to MG1 and MG2 mucins. MG1 has been found to be the major carrier of ABH antigens in saliva by Western analyses (Prakobphol et al, 1993) and intense ABH immunoreactivity is observed in mucous cells of salivary glands (Hamper et al, 1986) , which is the origin of MG1 synthesis. In contrast, MG2 has been reported to carry short carbohydrate side chains, predominantly sialosyl-T (Reddy et al, 1985) , which in salivary glands are found mainly in some serous cells (Therkildsen et al, 1994) , in accordance with our results indicating that MG2 is synthesized in serous cells.
It is interesting to note that the parotid glands, which only consist of serous cells, do not synthesize MG2. This is in accordance with previous Northern blot analyses that did not detect MUC7 transcripts in parotid glands (Bobek et al, 1993) . Thus, serous cells from different salivary glands vary in their ability to express MG2. Interestingly, high and a low molecular weight mucins have also been isolated from rodent (Moschera and Pigman, 1975) and bovine (Corfield et al, 1991) salivary glands. A low molecular weight, monomeric mucin has been cloned from rat submandibular gland (Albone et al, 1994) , and a homolog was recently cloned from mouse submandibular gland (Denny et al, 1996) . These mucins show no sequence similarity to other known mucins but have been proposed by Denny et al. to resemble human MUC7. The low molecular weight mouse submandibular mucin transcript was localized to seromucous cells by in situ hybridization (Denny et al, 1996) , and a rat submandibular mucin probably encoded by the gene reported by Albone et al. was also localized to seromucous cells by immunohistochernistry (Moreira et al, 1989) . In contrast, immunohistochemistry showed that the low molecular weight rat mucin was not produced in mucous cells of the sublingual glands (Vreugdenhil et al, 1982; Moreira et al, 1989) , which synthesize another, probably high molecular weight mucin (Vreugdenhil et al, 1982) . Thus, low molecular weight monomeric salivary mucins originating from cells with serous phenotypes from submandibular glands are found in both humans and rodents. Furthermore, rat parotid gland was found not to express the rat submandibular gland mucin by Northern blot analysis (Albone et al., 1994) , as human parotid gland does not express MUC7. The weak expression of rat submandibular mucin detected in rat sublingual glands by Northern blot analysis (Albone et al, 1994) may be derived from serous demilunes.
In conclusion, the present data indicate that a major fraction of human high molecular weight salivary mucin is composed of MUC5B, and that MUC5B and MUC7 are differentially expressed in salivary glands. The specificity of MAb PANH2 to high molecular weight salivary mucin (MG1) and MAb PANH3 to low molecular weight salivary mucin (MG2) were confirmed by cDNA cloning and in situ hybridization. Thus, these antibodies and in situ hydridization probes constitute useful reagents for the identification of salivary mucins and cell types of salivary glands, which may prove of value in the study of diseases of salivary glands.
Materials and methods
Monoclonal antibody
The MAb PANH2 (IgGl) was raised against partially deglycosylated MG1 and shown to react with die peptide core of MG1 (Nielsen et ah, 1996) .
Salivary gland cDNA library
Two micrograms of poly(A)* RNA derived from a pool of salivary glands (Clontech) was primed with oligo-dT primer and random hexamers (Time Saver cDNA Synthesis Kit, Pharmacia Biotech). Double-stranded cDNA was ligated to adaptors with EcoVl overhangs and ligated into predigested and dephosphorylated XZAPH vector (Stratagene). The cDNA library was packaged with Gigapack HI Gold (Stratagene) and screened without amplification.
Screening of salivary gland cDNA library
Screening of the cDNA library in Kcoli strain XLl (Stralagene) was done according to the manufacturer's instructions. A single positive clone, SALl, was identified. SALl did not exhibit reactivity with an irrelevant MAb of the same subclass or secondary antiserum alone. A pBluescript fragment containing SALl was sequenced with T7/T3 vector primers by making overlapping nested deletions from both the 5' and the 3' end of SALl (Erase-a-base kit, Promega). Sequences were obtained from a ABI377 automated sequencer (Perkin Elmer/Applied Biosystems) using the dye terminator kit (Perkin Elmer/Applied Biosystems) and by manual Sanger sequencing using -y-P 32 labeled primers (AmpliTaq, Perkin Elmer Cetus).
Isolation of genomic PI clones
PNEB1 (5'-TCGAATTCGGCTCCTGCCCGGGAGCGTCCAAG-3'; sense) and PNEB2 (5'-TCGAATTCCATGGGCGCAGGGACACAGAAGG-3'; antisense) from pSM2-l were used in PCR on 100 ng genomic DNA to amplify the corresponding genomic fragment. The PCR product was electrophorcsed and blotted onto nylon membrane (Hybond-N + , Amersham). The blot was probed with a labeled nested primer PNEB4 (5'-TCGAATTCCACGAG-GAGACGGTGCCCTTGCAC-3'). The PNEB1-PNEB2 primeT set was used to select 3 geoomic PI clones: DMPC-HFF#l-1104-H12, DMPC-HFF#1-1295-F3, and DMPC-HFF#l-476-B10 (Genome Systems). PI clones were grown in culture and DNA isolated from clones according to the suppliers instructions.
Southern blots of PI clone
PI clone DMPC-HFF#l-1104-H12 was digested with EcoRL electrophoresed in duplicate on a 0.6% agarose gel, and transferred onto nylon membrane. The excised SALl insert was gel purified, labeled with a-P by ruck translation (Oligolabeling Kit, Pharmacia Biotech) and used as a probe. A pSM2-l probe was prepared by RT-PCR using PNEB2 and PNEB3 (5'-TCGAATTCCACCCAGGACCCAACGGTGCAA-3') from human salivary gland poly(A)* RNA. The product was verified by probing with nested primer PNEB4, gel purified, labeled, and used as a probe. Southern blots were washed to a stringency of 0.1 x SSC at 70°C.
RT-PCR of the 3' end ofMUC5B
An antisense oligonucleotide (PNEB5; 5'-TCGAATTCGACGCACTCCCCA-CAGCACTGC-3') from pSM2-l (Troxler«ai, 1995) was synthesized (Pharmacia Biotech) and used to prime a RT reaction (Expand Reverse Transcriptase, Boehringer Mannheim). Sense oligonucleotide primers corresponding to the 3' end sequences of MUC5B clones JER 57 (5'-TCGAATTCCACCCAT-GTCCACCATGTCCAC-3'), JUL 10 , JER 28, and JUL 7 were synthesized (Pharmacia Biotech). A PCR reaction using JER 57 and PNEB5 primers was performed using the Expand Long Template PCR System (Boehringer Mannheim). The PCR product was electrophoresed and transferred onto nylon membrane. The blot was probed using a labeled nested primer from the pSM2-l sequence (PNEB3: 5'-TCGAATTCCACCCAGGACCCAACGGTG-CAATG-3'). A hybridization positive band was purified and partially sequenced with PNEB5, PNEB3, and the JER 57 primer for verification of identity.
Northern analyses with SALl
Two (ig each of poly(A)* RNA from a pool of salivary glands, testis and thymus (Clontech) were electrophoresed on a denaturing gel together with a RNA ladder (0.24-9.5 kb RNA ladder, Gibco BRL) and transferred to nylon membrane (GeneScreen Plus, Biotechnology Systems NEN Reasearch Products). The SALl insert was excised from the vector, gel purified (Prep-a-gene, Bio-Rad) and labeled with a-P 32 by nick translation (Oligolabeling Kit, Pharmacia Biotech). The blot was probed overnight, washed to a stringency of 0. lx SSC (1 x SSC = 0.3M NaCl, 0.3 M sodium citrate) at 70°C and exposed for 10 h to X-OMAT film (Eastman Kodak). Control included reprobing with an actin probe.
In situ hybridization 30-mer antisense alkaline phosphatase-conjugated DNA oligonucleotide probes were synthesized (DNA Technology). The sequences were: SALl (MUC5B): 5'-GCGGGTCCAGGTGGTGCCCAGGGAGGAGGA-3', MUC7: 5'-GTGGAGCTGGTGTAGTTGCAGAAGGTGTGG-3'. The probe against SALl was antisense to the 3' end of SALl, since this probe would recognize the tandem repeats of MUC5B transcripts allowing for amplification of the hybridization signal. An identical sense sequence was also found in MUC5B cDNA clone JER 57 (Dufosse et aL, 1993) . The probe against MUC7 was antisense to the tandem repeats of MUC7 transcripts. In situ hybridization was carried out as described previously (Fahrenkrug et aL, 1996) . Sections from parotid (two samples), submandibular (two samples), sublingual (three samples), palatine (one sample), and labial (five samples) salivary glands were used. Briefly, paraffin sections were dewaxed and treated with 0.1% pronase (Dako) in phosphate-buffered saline at room temperature for 10 min. Frozen sections were thawed, fixed in 4% paraformaldehyde, treated with 0.25% acetic anhydrid/0.1 M triethanolamine/0.9% NaCl, and dehydrated. Hybridization was performed at 37°C overnight with hybridization buffer containing 50% formamide, followed by washing to a stringency of 0.1 x SSC al 37°C and development with nitro blue tetrazolium/5-bromo-4-chloro-3-indolyl phosphate (Sigma). The sections were counteraained with 0.2% eosin (Sigma).
